NEW YORK and MELBOURNE, Australia, June 18, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing ...
Stocktwits on MSN
Why did RVPH stock crash 50% today?
FDA recommended that Reviva conduct a second Phase 3 clinical trial to generate additional efficacy data and expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback